Fristad M, Roley-Roberts M, Black S, Eugene Arnold L
J Affect Disord. 2020; 281:24-32.
PMID: 33285389
PMC: 7856236.
DOI: 10.1016/j.jad.2020.11.115.
Bauer I, Suchting R, Van Rheenen T, Wu M, Mwangi B, Spiker D
Cogn Neuropsychiatry. 2019; 24(2):93-107.
PMID: 30774035
PMC: 6675623.
DOI: 10.1080/13546805.2019.1580190.
Fristad M
J Clin Psychol Med Settings. 2018; 23(4):323-326.
PMID: 30140148
PMC: 5139678.
DOI: 10.1007/s10880-016-9469-4.
Lee D, Won E, Choi J, Min H, Kim J, Ha K
Psychiatry Investig. 2017; 14(5):585-594.
PMID: 29042883
PMC: 5639126.
DOI: 10.4306/pi.2017.14.5.585.
Jones L, Black S, Eugene Arnold L, Fristad M
J Clin Child Adolesc Psychol. 2017; 48(sup1):S227-S233.
PMID: 28715242
PMC: 9003566.
DOI: 10.1080/15374416.2017.1342547.
Omega-3 Fatty Acid Plasma Levels Before and After Supplementation: Correlations with Mood and Clinical Outcomes in the Omega-3 and Therapy Studies.
Eugene Arnold L, Young A, Belury M, Cole R, Gracious B, Seidenfeld A
J Child Adolesc Psychopharmacol. 2017; 27(3):223-233.
PMID: 28157380
PMC: 5397211.
DOI: 10.1089/cap.2016.0123.
Neurocognitive functioning in individuals with bipolar disorder and their healthy siblings: A preliminary study.
Bauer I, Wu M, Frazier T, Mwangi B, Spiker D, Zunta-Soares G
J Affect Disord. 2016; 201:51-6.
PMID: 27179338
PMC: 4899217.
DOI: 10.1016/j.jad.2016.04.026.
A Randomized Controlled Trial of Individual Family Psychoeducational Psychotherapy and Omega-3 Fatty Acids in Youth with Subsyndromal Bipolar Disorder.
Fristad M, Young A, Vesco A, Nader E, Healy K, Gardner W
J Child Adolesc Psychopharmacol. 2015; 25(10):764-74.
PMID: 26682997
PMC: 4691654.
DOI: 10.1089/cap.2015.0132.
Affective Processing in Pediatric Bipolar Disorder and Offspring of Bipolar Parents.
Bauer I, Frazier T, Meyer T, Youngstrom E, Zunta-Soares G, Soares J
J Child Adolesc Psychopharmacol. 2015; 25(9):684-90.
PMID: 26468988
PMC: 4653817.
DOI: 10.1089/cap.2015.0076.
Validity of the Expressed Emotion Adjective Checklist (EEAC) in Caregivers of Children with Mood Disorders.
Klaus N, Perez Algorta G, Young A, Fristad M
Couple Family Psychol. 2015; 4(1):27-38.
PMID: 25729632
PMC: 4339054.
DOI: 10.1037/cfp0000036.
Three-year latent class trajectories of attention-deficit/hyperactivity disorder (ADHD) symptoms in a clinical sample not selected for ADHD.
Eugene Arnold L, Ganocy S, Mount K, Youngstrom E, Frazier T, Fristad M
J Am Acad Child Adolesc Psychiatry. 2014; 53(7):745-60.
PMID: 24954824
PMC: 4224147.
DOI: 10.1016/j.jaac.2014.03.007.
Unfiltered Administration of the YMRS and CDRS-R in a Clinical Sample of Children.
Yee A, Perez Algorta G, Youngstrom E, Findling R, Birmaher B, Fristad M
J Clin Child Adolesc Psychol. 2014; 44(6):992-1007.
PMID: 24885078
PMC: 4254390.
DOI: 10.1080/15374416.2014.915548.
Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder.
Findling R, Cavus I, Pappadopulos E, Vanderburg D, Schwartz J, Gundapaneni B
J Child Adolesc Psychopharmacol. 2013; 23(8):545-57.
PMID: 24111980
PMC: 3804078.
DOI: 10.1089/cap.2012.0029.
Future directions for research on youth with bipolar spectrum disorders.
Fristad M, Perez Algorta G
J Clin Child Adolesc Psychol. 2013; 42(5):734-47.
PMID: 23915232
PMC: 4137316.
DOI: 10.1080/15374416.2013.817312.
Examination of disruptive behavior outcomes and moderation in a randomized psychotherapy trial for mood disorders.
Boylan K, MacPherson H, Fristad M
J Am Acad Child Adolesc Psychiatry. 2013; 52(7):699-708.
PMID: 23800483
PMC: 4326010.
DOI: 10.1016/j.jaac.2013.04.014.
Predictors and moderators in the randomized trial of multifamily psychoeducational psychotherapy for childhood mood disorders.
MacPherson H, Perez Algorta G, Mendenhall A, Fields B, Fristad M
J Clin Child Adolesc Psychol. 2013; 43(3):459-72.
PMID: 23795823
PMC: 3797211.
DOI: 10.1080/15374416.2013.807735.
What goes up must come down: the burden of bipolar depression in youth.
VAN Meter A, Henry D, West A
J Affect Disord. 2013; 150(3):1048-54.
PMID: 23768529
PMC: 3759628.
DOI: 10.1016/j.jad.2013.05.039.
Clinical significance of treatment effects with aripiprazole versus placebo in a study of manic or mixed episodes associated with pediatric bipolar I disorder.
Youngstrom E, Zhao J, Mankoski R, Forbes R, Marcus R, Carson W
J Child Adolesc Psychopharmacol. 2013; 23(2):72-9.
PMID: 23480324
PMC: 3696952.
DOI: 10.1089/cap.2012.0024.
A prospective open-label trial of paliperidone monotherapy for the treatment of bipolar spectrum disorders in children and adolescents.
Joshi G, Petty C, Wozniak J, Faraone S, Spencer A, Woodworth K
Psychopharmacology (Berl). 2013; 227(3):449-58.
PMID: 23397049
DOI: 10.1007/s00213-013-2970-7.
Abnormal amygdala and prefrontal cortex activation to facial expressions in pediatric bipolar disorder.
Garrett A, Reiss A, Howe M, Kelley R, Singh M, Adleman N
J Am Acad Child Adolesc Psychiatry. 2012; 51(8):821-31.
PMID: 22840553
PMC: 3408885.
DOI: 10.1016/j.jaac.2012.06.005.